Search
Menu
Home
Sources
About
Contacts
Monalizumab
Monalizumab
is an
investigational drug
being
studied
for
rheumatoid arthritis
,
gynecologic malignancies
and other
cancers
.
Mechanism
of
action
Monalizumab is a
monoclonal antibody
targeted at NKG2A. It is a
checkpoint inhibitor
.